difference between semaglutide & tirzepatide vs. Ozempic: Comparing Diabetes Treatments Weight Loss Benefits Weight loss isn't one-size-fits-all. Both

With ongoing support, weight loss often follows shortly after

Clients Response to GLP-1: Each individuals response to GLP-1 receptor agonists can vary

A different non-insulin injectable diabetes medication Victoza (liraglutide) was approved in 2010, but in 2013, the FDA issued a warning to consumers of possible increased risk of pancreatitis and pre-cancerous findings of the pancreas. And this first warning isnt an anomaly

24 Semaglutide is a glucagon-like peptide 1 receptor agonist approved for the treatment of overweight and obesity that leads to a mean weight loss of 15% after 68 wk, weight loss that is superior to other antiobesity medications

Summary: A Tool, Not a Magic Wand Berberine is interesting because it targets metabolic pathways and may improve some cardiometabolic markers